This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Earnings per Diluted Share of Natus Medical Incorporated with missing and latest data points interpolated. Earnings per diluted share as calculated and reported by the company. Approximates to the amount of Net Income for the period per each Weighted Average Shares Diluted.
|10 Years Trend|
Compare to Other EquitiesAll Fundamental Data
Natus Medical Earnings per Diluted Share Over Time